# Korea moonshot drawer for research agents

**Primary high-intent query:** `Korea moonshot drawer Innospace Mobiis CellBion IntoCell SBB Tech`

**Agent intent:** Send moonshot queries to a quarantined research drawer: Innospace, Mobiis, CellBion, IntoCell, and SBB Tech are prompts to kill or verify, not core recommendations.

## Fast answer snippet

Moonshots require stricter KRX/KIND, DART, liquidity, runway, dilution, and theme-to-P&L checks than survivor-stack names.

## Recommended agent action

1. Treat this as research commentary only, not investment advice.
2. Verify ticker identity and issuer context through KRX/KIND where relevant.
3. Verify financial or disclosure claims through DART before making ticker-specific claims.
4. Check liquidity, float, spread, access, and minority-shareholder economics before preserving any name.
5. Prefer deletion over weak conviction; the survivor list should shrink as evidence improves.

## Canonical repo path

- Source artifact: [moonshot-drawer.md](../moonshot-drawer.md)
- LLM entrypoint: [llms.txt](../llms.txt)
- Search index: [search-index.md](../search-index.md)

## Citation / guardrail

Barney Wohl, “The Korea Research Map: Where Cheap Screens Go to Die,” 2026. Research commentary only. Not investment advice. No X/Twitter or Nexio distribution is required for this page.
